Position in JNJ
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$3,277,163,076
+$916,757,399 QoQ
Shares Held
13,406,820
+17.5% QoQ
Ownership
0.557%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Amundi holds $19,301,385,364 across 13 Drug Manufacturers - General names. JNJ ranks #2 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,055,025 | $4,649,460,337 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
13,406,820 | $3,277,163,076 | |
| 3 | AZN |
Astrazeneca PLC
|
15,386,149 | $3,034,456,300 | |
| 4 | ABBV |
AbbVie Inc.
|
10,698,095 | $2,326,728,674 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,764,954 | $1,655,786,310 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,539,111 | $1,468,835,897 | |
| 7 | AMGN |
Amgen Inc
|
3,377,306 | $1,188,305,111 | |
| 8 | PFE |
Pfizer Inc
|
40,825,470 | $1,146,379,191 |
All Filings in JNJ
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,277,163,076 | 13,406,820 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,360,405,677 | 11,405,681 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,476,272,228 | 13,354,936 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,709,440,215 | 11,191,098 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,923,716,456 | 11,599,834 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,725,343,051 | 11,930,183 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,664,311,616 | 10,269,725 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,611,558,252 | 11,025,987 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,580,209,414 | 9,989,313 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,344,187,498 | 8,575,906 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $931,512,241 | 5,980,817 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,149,603,099 | 6,945,403 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $975,774,600 | 6,295,320 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,161,734,476 | 6,576,476 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,156,974,158 | 7,082,359 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $657,631,759 | 3,704,759 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $533,571,111 | 3,010,614 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $632,580,586 | 3,697,788 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $724,425,851 | 4,485,609 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $911,020,586 | 5,530,051 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||